Availability to antibiotics of particular importance – A Swedish pilot study of an alternative reimbursement model
LyssnaIn a pilot project, the Public Health Agency of Sweden has investigated whether a model with guaranteed reimbursement to the pharmaceutical company can improve access to particularly important antibiotics in Sweden. An initial evaluation shows that the studied reimbursement model led to increased access to the antibiotic products in our country, earlier than in other comparable European countries.
Related reading
Författare:
Folkhälsomyndigheten
Publicerad:
Uppdaterad:
Antal sidor:
3
Artikelnummer:
23189